The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 03, 2025
Filed:
Mar. 08, 2024
Applicant:
Immatics Biotechnologies Gmbh, Tuebingen, DE;
Inventors:
Ricarda Hannen, Tuebingen, DE;
Jens Hukelmann, Tuebingen, DE;
Florian Koehler, Tuebingen, DE;
Daniel Johannes Kowalewski, Tuebingen, DE;
Heiko Schuster, Tuebingen, DE;
Oliver Schoor, Tuebingen, DE;
Michael Roemer, Tuebingen, DE;
Chih-Chiang Tsou, Houston, TX (US);
Jens Fritsche, Tuebingen, DE;
Assignee:
Immatics Biotechnologies GmbH, Tübingen, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2025.01); A61K 39/00 (2006.01); A61K 40/11 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 39/0011 (2013.01); A61K 40/11 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2018.01); C07K 14/4748 (2013.01); C12N 5/0636 (2013.01);
Abstract
The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 216, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.